drugset / Trial / NCT00226044

Rectal and Oral Omeprazole Treatment of Reflux Disease in Infants.

NCT00226044

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to compare the efficacy of oral and rectal omeprazole treatment in infants with gastroesophageal reflux due to esophageal atresia or congenital diaphragmatic hernia.

Timeline

Start
2005-09
Primary completion
2016-09
Completion
2017-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Omeprazole Other / unclassified 1 mg/kg Rectal